Page last updated: 2024-09-05

anidulafungin and triazoles

anidulafungin has been researched along with triazoles in 78 studies

Compound Research Comparison

Studies (anidulafungin)	Trials (anidulafungin)	Recent Studies (post-2010) (anidulafungin)	Studies (triazoles)	Trials (triazoles)	Recent Studies (post-2010) (triazoles)
568	33	331	25,808	2,252	13,501

Research

Studies (78)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (3.85)	18.2507
2000's	22 (28.21)	29.6817
2010's	49 (62.82)	24.3611
2020's	4 (5.13)	2.80

Authors

Authors	Studies
Espinel-Ingroff, A	2
Baquero, F	1
Bernal, S; Chávez, M; Gutierrez, MJ; Mazuelos, EM; Quindós, G; Valverde, A	1
Chiou, CC; Groll, AH; Walsh, TJ	1
Andriole, VT; Marino, S; Roberts, J; Schock, K	1
Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A	1
Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J	1
Gupta, AK; Tomas, E	1
Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, JR	1
Steinbach, WJ	1
Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Philip, A; Rex, JH; Rodriguez, J	1
Baker, CJ; Pannaraj, PS; Walsh, TJ	1
Baruch, A; Dowell, JA; Foster, G; Schranz, J	1
Scheinfeld, N	1
Dierich, MP; Jost, D; Lass-Flörl, C; Perkhofer, S	1
Chu, CC; Hsueh, PR; Ruan, SY	1
Bernhardt, H; Knoke, M	1
Cubillos, GF; Kett, DH	1
Bakker-Woudenberg, IA; Mathot, RA; Rijnders, BJ; Tavakol, M; ten Kate, MT; van de Sande, WW; van Vianen, W	1
Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ	1
Kang, CI; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM	1
Lass-Flörl, C; Perkhofer, S	1
Banevicius, MA; Crandon, JL; Crownover, PH; Fang, AF; Knauft, RF; Kuti, JL; Nicolau, DP; Pope, JS; Russomanno, JH; Shore, E	1
Mazzei, T; Novelli, A	1
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ	1
Chatzimoschou, A; Cotten, CJ; Diza-Mataftsi, E; Katragkou, A; Kruhlak, MJ; Paliogianni, F; Roilides, E; Simitsopoulou, M; Taparkou, A; Tsantali, C; Walsh, TJ	1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA	1
Castanheira, M; Jones, RN; Pfaller, MA	1
Aznar, J; de Toro, M; Maite, R; Torres, MJ	1
Bille, J; Calandra, T; Decosterd, LA; Marchetti, O; Mercier, T; Pesse, B; Rochat, B; Tissot, F; Widmer, N; Zanolari, B	1
Heijink, A; Patel, R; Rouse, MS; Steckelberg, JM	1
Chatzimoschou, A; Georgiadou, E; Katragkou, A; Roilides, E; Simitsopoulou, M	1
Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR	1
De Rosa, FG; Falcone, M; Ghezzi, MC; Pasero, D; Raponi, G; Russo, A; Toma, L; Venditti, M	1
Antachopoulos, C; Chatzimoschou, A; Georgiadou, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ	1
George, J; Reboli, AC	1
Bernhardt, H; Bernhardt, J; Knoke, M	1
Castanheira, M; Duncanson, F; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA	1
Demitrovicova, A; Kisac, P; Krcmery, V	1
Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA	1
Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Salas, V	1
Fortún, J	1
Bowman, CJ; Chmielewski, G; Cross, DM; Lewis, EM; Liu, L; Modesitt, MS; Ripp, SL; Sawaryn, CM	1
Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G	1
Alou, L; Cafini, F; Corcuera, MT; Gómez-Aguado, F; González, N; Guinea, J; Prieto, J; Sevillano, D	1
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC	1
Drogari-Apiranthitou, M; Grammatikou, M; Kanioura, L; Mantopoulou, FD; Mitroussia-Ziouva, A; Petrikkos, G; Skiada, A; Tsakris, A; Vrioni, G	1
Andersen, N; Baltch, AL; Bopp, LH; Carlyn, CJ; Lawrence, D; Michelsen, PB; Ritz, WJ; Smith, RP	1
Chandrasekar, PH; Krishnan-Natesan, S; Wu, W	1
Alanio, A; Bougnoux, ME; Dannaoui, E; Ducroz, S; Lortholary, O; Planche, V	1
Al-Nakeeb, Z; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Warn, PA	1
Brüggemann, RJ; Melchers, WJ; Mouton, JW; Seyedmousavi, S; Verweij, PE	1
Brüggemann, RJ; Melchers, WJ; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE	1
Melchers, WJ; Meletiadis, J; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE	1
Chen, HT; Chu, WL; Lin, CC; Lo, HJ; Yang, YL	1
Brock, M; Galiger, C; Ibrahim-Granet, O; Jouvion, G; Parlato, M; Savers, A	1
Co, VM; Hsueh, PR; Mootsikapun, P; Ong, ML; Rajadhyaksha, V; Talwar, D	1
Abreu, P; Colombo, AL; Magana, M; Nucci, M; Petti, M; Sanchez, SP; Schlamm, HT	1
Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA	1
Capilla, J; Fernández-Silva, F; Guarro, J; Mayayo, E; Sutton, D	1
Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R	1
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF	1
Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S	1
Arslan, U; Dagi, HT; Findik, D; Senkeles, C	1
Legendre, DP; Muzny, CA; Riley, TT; Swiatlo, E	1
Capilla, J; Guarro, J; Martin-Vicente, A	1
Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E	1
Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K	1
Agurto, C; Bustamante, B; Diaz, A; Hidalgo, J; Huaroto, L; Illescas, R; Ramirez, R; Rodriguez, L	1
Courbin, V; Dannaoui, E; Jullien, V; Raffetin, A	1
Bedin Denardi, L; de Azevedo, MI; Hartz Alves, S; Keller, JT; Morais Santurio, J; Oliveira, V; Pantella Kunz de Jesus, F; Weiblen, C	1
Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E	1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E	1
Candoni, A; Facchin, G; Fanin, R; Lazzarotto, D	1
Bedin Denardi, L; Brüggemann, RJM; Buil, JB; Melchers, WJG; Verweij, PE	1
Castanheira, M; Deshpande, LM; Messer, SA; Pfaller, MA; Rhomberg, PR; Utt, EA	1
Abidi, MZ; Crowther, B; Gleason, T; Gray, A; Grazia, TJ; Porter, K; Sartain, E; Schoeppler, K; Smith, JB; Steele, M	1

Reviews

13 review(s) available for anidulafungin and triazoles

Article	Year
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. The oncologist, 2000, Volume: 5, Issue:2 Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2000
New antifungal agents. Dermatologic clinics, 2003, Volume: 21, Issue:3 Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2003
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Revista iberoamericana de micologia, 2003, Volume: 20, Issue:4 Topics: Anidulafungin; Antifungal Agents; Echinocandins; Fungi; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycology; Peptides, Cyclic; Triazoles	2003
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
A review of the new antifungals: posaconazole, micafungin, and anidulafungin. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:12 Topics: Administration, Oral; Anidulafungin; Antifungal Agents; Dermatomycoses; Echinocandins; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Micafungin; Triazoles	2007
Anidulafungin in the treatment of patients with invasive candidiasis. International journal of antimicrobial agents, 2008, Volume: 32 Suppl 2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole	2008
Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination. Expert opinion on investigational drugs, 2009, Volume: 18, Issue:9 Topics: Anidulafungin; Animals; Antifungal Agents; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Synergism; Echinocandins; Humans; Molecular Structure; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2009
Pharmacological properties of antifungal drugs with a focus on anidulafungin. Drugs, 2009, Volume: 69 Suppl 1 Topics: Anidulafungin; Animals; Antifungal Agents; Echinocandins; Fungi; Humans; Polyenes; Triazoles	2009
Traditional and emerging antifungal therapies. Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2010
Anidulafungin: when and how? The clinician's view. Mycoses, 2012, Volume: 55, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
[Antifungal therapy update: new drugs and medical uses]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 5 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Early Diagnosis; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Salvage Therapy; Treatment Outcome; Triazoles	2011
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:9 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Debridement; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles; Virulence	2016
Therapeutic tools for oral candidiasis: Current and new antifungal drugs. Medicina oral, patologia oral y cirugia bucal, 2019, Mar-01, Volume: 24, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles	2019

Trials

5 trial(s) available for anidulafungin and triazoles

Article	Year
Safety and pharmacokinetics of coadministered voriconazole and anidulafungin. Journal of clinical pharmacology, 2005, Volume: 45, Issue:12 Topics: Adult; Anidulafungin; Antifungal Agents; Cross-Over Studies; Drug Therapy, Combination; Echinocandins; Humans; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Adult; Anidulafungin; Antifungal Agents; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Echinocandins; Female; Humans; Injections, Intravenous; Male; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole; Young Adult	2009
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2012
Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial. BMC infectious diseases, 2013, May-15, Volume: 13 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Anidulafungin; Antifungal Agents; Candidemia; Echinocandins; Female; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2013
An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America. Mycoses, 2014, Volume: 57, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Echinocandins; Female; Humans; Latin America; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2014

Other Studies

60 other study(ies) available for anidulafungin and triazoles

Article	Year
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. Journal of clinical microbiology, 1998, Volume: 36, Issue:10 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Culture Media; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Structure-Activity Relationship; Triazoles; Yeasts	1998
[Antifungal drugs: the new frontier]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:3 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole	1998
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:5 Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Oral; Echinocandins; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	1999
Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:12 Topics: Anidulafungin; Animals; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Disease Models, Animal; Echinocandins; Liver; Lung; Peptides, Cyclic; Rabbits; Thiazoles; Triazoles	2000
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp. Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:2 Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole	2003
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001). Diagnostic microbiology and infectious disease, 2003, Volume: 46, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole	2003
In vitro activity of anidulafungin against selected clinically important mold isolates. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Echinocandins; Fungi; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus; Drug Synergism; Echinocandins; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Advances in antifungal therapy. The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole	2005
Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5 Topics: Anaerobiosis; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Echinocandins; Hyphae; Microbial Sensitivity Tests; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole	2008
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
[What distinctions do Candida biofilms have to offer?]. Mycoses, 2008, Volume: 51 Suppl 3 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Culture Media; Drug Resistance, Fungal; Echinocandins; Glucose; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole	2008
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Rats; Treatment Outcome; Triazoles; Voriconazole	2009
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole	2009
Anidulafungin treatment of candidal central nervous system infection in a murine model. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System Infections; Disease Models, Animal; Echinocandins; Female; Mice; Pyrimidines; Triazoles; Voriconazole	2009
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2010
Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. The Journal of infectious diseases, 2010, Jun-15, Volume: 201, Issue:12 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Cytokines; Echinocandins; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Microbial Viability; Microscopy, Confocal; Oxidation-Reduction; Phagocytes; Pyrimidines; Respiratory Burst; Rhodamines; Staining and Labeling; Triazoles; Voriconazole	2010
Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Anidulafungin; Antifungal Agents; Candida; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2010
Characterization of Candida parapsilosis complex isolates. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidemia; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole	2011
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspo Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Anidulafungin; Antifungal Agents; Blood Chemical Analysis; Caspofungin; Chromatography, Liquid; Echinocandins; Humans; Itraconazole; Lipopeptides; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole	2010
Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro? Clinical orthopaedics and related research, 2011, Volume: 469, Issue:5 Topics: Anidulafungin; Antifungal Agents; Drug Carriers; Drug Implants; Echinocandins; Polymethyl Methacrylate; Pyrimidines; Solubility; Time Factors; Triazoles; Voriconazole	2011
Additive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:3 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Echinocandins; Humans; Microbial Viability; Monocytes; Neutrophils; Staining and Labeling; Tetrazolium Salts; Triazoles	2011
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Clinical experience of anidulafungin for the treatment of patients with documented candidemia. Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Catheters, Indwelling; Cross Infection; Echinocandins; Female; Fluconazole; Humans; Italy; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2010
Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Plankton; Pyrimidines; Triazoles; Voriconazole	2011
Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation. Mycoses, 2011, Volume: 54, Issue:6 Topics: Aerobiosis; Anaerobiosis; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidemia; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11 Topics: Aminopyridines; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5 Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Slovakia; Treatment Outcome; Triazoles	2011
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2012
Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus. Mycopathologia, 2012, Volume: 173, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Drug Therapy, Combination; Echinocandins; Humans; Male; Mice; Pyrimidines; Triazoles; Voriconazole	2012
Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan. Regulatory toxicology and pharmacology : RTP, 2012, Volume: 63, Issue:1 Topics: Administration, Oral; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Drug Combinations; Drug Evaluation, Preclinical; Echinocandins; Female; Injections, Subcutaneous; Male; Pyrimidines; Rats; Rats, Inbred F344; Research Design; Sex Factors; Toxicity Tests; Triazoles; Voriconazole	2012
Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2012, Volume: 25, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Colorimetry; Culture Media; Drug Combinations; Echinocandins; Humans; Microbial Sensitivity Tests; Protein Binding; Pyrimidines; Serum Albumin; Tetrazolium Salts; Time Factors; Triazoles; Voriconazole	2012
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates. Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Drug Synergism; Echinocandins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles	2012
Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide. Chemotherapy, 2012, Volume: 58, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Chemokines; Cytokines; Echinocandins; Humans; Lipopolysaccharides; Macrophages; Pyrimidines; Triazoles; Voriconazole	2012
In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus. Diagnostic microbiology and infectious disease, 2012, Volume: 73, Issue:2 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Azoles; Drug Combinations; Echinocandins; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cell Line; Chromatography, High Pressure Liquid; Drug Interactions; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Models, Theoretical; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole	2012
Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Echinocandins; Female; Fungal Proteins; Humans; Mice; Mutation; Neutrophils; Promoter Regions, Genetic; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2013
Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Mice; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2013
In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Microbial Sensitivity Tests; Point Mutation; Promoter Regions, Genetic; Pyrimidines; Tandem Repeat Sequences; Triazoles; Voriconazole	2013
Species distribution and drug susceptibilities of Candida isolates in TSARY 2010. Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:2 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole	2013
Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Echinocandins; Luminescent Measurements; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2013
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole	2013
In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Acremonium; Amphotericin B; Anidulafungin; Antifungal Agents; Drug Combinations; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2014
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs. Mycoses, 2015, Volume: 58, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole	2015
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole	2015
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses. Mycopathologia, 2016, Volume: 181, Issue:3-4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole	2016
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Annals of clinical microbiology and antimicrobials, 2016, May-31, Volume: 15, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole	2016
Synergistic effect of anidulafungin combined with posaconazole in experimental aspergillosis. Medical mycology, 2017, Jun-01, Volume: 55, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Kidney; Male; Mice; Survival Analysis; Triazoles	2017
New pharmacological opportunities for the treatment of invasive mould diseases. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1 Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole	2017
Changing epidemiology of candidaemia in Australia. The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4 Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole	2017
A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes. PloS one, 2017, Volume: 12, Issue:4 Topics: Adolescent; Adult; Aged; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Peru; Prospective Studies; Triazoles; Voriconazole; Young Adult	2017
Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus nidulans; Aspergillus niger; Drug Combinations; Drug Resistance, Fungal; Humans; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles	2018
Evaluation of the efficacy of a posaconazole and anidulafungin combination in a murine model of pulmonary aspergillosis due to infection with Aspergillus fumigatus. Diagnostic microbiology and infectious disease, 2018, Volume: 90, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Lung; Mice; Pulmonary Aspergillosis; Treatment Outcome; Triazoles	2018
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports, 2019, 03-07, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult	2019
18F-FDG Positron Emission Tomography (PET) Scan as a Useful Tool to Assess Response to Antimycotic Therapy in Disseminated Invasive Mycosis in Acute Myeloid Leukemia. Mycopathologia, 2020, Volume: 185, Issue:3 Topics: Aged; Anidulafungin; Antifungal Agents; Drug Combinations; Humans; Immunocompromised Host; Invasive Fungal Infections; Kidney; Leukemia, Myeloid, Acute; Liver; Male; Mycoses; Nitriles; Positron-Emission Tomography; Pyridines; Spleen; Treatment Outcome; Triazoles	2020
In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates. The Journal of antimicrobial chemotherapy, 2020, 09-01, Volume: 75, Issue:9 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles	2020
Antifungal drugs work together to treat germs causing fungal infections. Future microbiology, 2021, Volume: 16 Topics: Anidulafungin; Antifungal Agents; Candida auris; Candidiasis, Invasive; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Nitriles; Pyridines; Triazoles; Voriconazole	2021
Perioperative anidulafungin combined with triazole prophylaxis for the prevention of early invasive candidiasis in lung transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:4 Topics: Anidulafungin; Candidiasis, Invasive; Humans; Lung; Retrospective Studies; Transplant Recipients; Triazoles	2021